Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
COVID Symptoms |
Schedule a COVID vaccine or booster appointment:
Log in to myPennMedicine or call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Sees patients age 18 and up
Sees patients age 18 and up
Penn Medicine University City
3737 Market Street
Philadelphia, PA 19104
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown above from our internal platform, PMX Feedback. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Pulmonary vascular disease: Therapeutics, outcomes
Goodman R, Chirinos JA, Ky B, Mazurek JA, Smith KA, Palevsky HI, Fritz JS, Pugliese SC, Kawut SM, Al-Naamani N: Systemic arterial properties in pulmonary hypertension Pulm Circ 11 (4): 2021.
Herzig M, Khandhar S, Palevsky H, Fritz J, Mehta M, Matthai W: Intermediate-term outcomes for patients with submassive pulmonary embolism treated with catheter-directed thrombolysis J Invasive Cardiol : JIC20211111-2. Online ahead of print,2021.
Frost A, Janmohamed M, Fritz JS, McConnell JW, Poch D, Fortin TA, Miller CE, Chin KM, Fisher M, Eggert M, McEvoy C, Benza RL, Farber HW, Kim NH, Pfister T, Shiraga Y, McLaughlin V: Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: results from the TRANSIT-1 study J Heart Lung Transplant Epub ahead of print : 2018.
Baird GL, Archer-Chicko C, Barr RG, Bluemke DA, Foderaro AE, Fritz JS, Hill NS, Kawut SM, Klinger JR, Lima JAC, Mullin CJ, Ouyang P, Palevsky HI, Palmisicano AJ, Pinder D, Preston IR, Roberts KE, Smith KA, Walsh T, Whittenhall M, Ventetuolo CE: Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension Eur Respir J 51 : 1800467,2018.
Narasimhan V, Palevsky HI, Smith KA, Fritz JS, Mazurek JA, Archer-Chicko CL, Burwell C, Pugliese S, Kawut SM, Al-Naamani N: Obesity in pulmonary arterial hypertension Am J Respir Crit Care Med 197 : A5709,2018.
Boyle K, Fargo JD, Fritz JS, Smith KA, Mazurek JA, Pinder D, Archer-Chicko CL, Palevsky HI, Pack AI, Sommers MS, Kawut SM, Matura LA: Reliability and construct validity of the patient-reported outcomes measurement information system (PROMIS) instruments in women with pulmonary arterial hypertension Am J Respir Crit Care Med 197 : A2640,2018.
Kawut SM, Archer-Chicko CL, DiMichele A, Fritz JS, Klinger JR, Ky B, Palevsky HI, Palmisciano AJ, Patel M, Pinder D, Propert KJ, Smith KA, Stanczyk F, Tracy R, Vaidya A, Whittenhall ME, Ventetuolo CE: Anastrozole in pulmonary arterial hypertension (AIPH): a randomized, double-blind placebo-controlled trial Am J Respir Crit Care Med 195 (3): 360,2017.
Matura LA, Fargo J, Fritz JS, Smith KA, Vaidya A, Pinder D, Archer-Chicko C, Palevsky HI, Pack AI, Sommers MS, Kawut SM: Slow-paced respiration therapy to treat symptoms in pulmonary arterial hypertension Heart Lung 46 (1): 7,2017.
Fritz JS: "Shortness of Breath: What Your Body Might Be Telling You" Penn Heart and Vascular Blog, https://www.pennmedicine.org/updates/blogs/heart-and-vascular-blog/2016/may/shortness-of-breath : 2016.
Courtright KR, Fritz JS, Haas AR: A lung mass, orthopnea, and syncope: tissue diagnosis should wait American Thoracic Society International Conference : 2016.
Harron Lung CenterPulmonary Vascular Disease ProgramPenn Medicine University City3737 Market St., 10th Floor
Patient appointments: 800-789-7366